Circular RNA circ_0000644 promotes papillary thyroid cancer progression via sponging miR-1205 and regulating E2F3 expression

References

• Wang LY, Ganly I. Post-treatment surveillance of thyroid cancer. Eur J Surg Oncol. 2018 Mar;44(3):357–366.
   PubMedGoogle Scholar
• Janjua N, Wreesmann VB. Aggressive differentiated thyroid cancer. Eur J Surg Oncol. 2018 Mar;44(3):367–377.
   PubMed Web of Science ®Google Scholar
• Chou CK, Liu RT, Kang HY. MicroRNA-146b: A novel biomarker and therapeutic target for human papillary thyroid cancer. Int J Mol Sci. 2017 Mar 15;18(3):636.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 american thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016 Jan;26(1):1–133.
   PubMed Web of Science ®Google Scholar
• Wilusz JE, Sharp PA. Molecular biology. A circuitous route to noncoding RNA. Science. 2013 Apr 26;340(6131):440–441.
   PubMed Web of Science ®Google Scholar
• Cai D, Liu Z, Kong G. Molecular and bioinformatics analyses identify 7 circular RNAs involved in regulation of oncogenic transformation and cell proliferation in human bladder cancer. Med Sci Monit. 2018 Mar 20;24:1654–1661.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhou LY, Tang X, et al. Circ-Foxo3 is positively associated with the Foxo3 gene and leads to better prognosis of acute myeloid leukemia patients. BMC Cancer. 2019 Sep 18;19(1):930.
   PubMed Web of Science ®Google Scholar
• Yang F, Hu A, Li D, et al. Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation. Mol Cancer. 2019 Nov13;18(1):158.
   PubMed Web of Science ®Google Scholar
• Wang F, Wang J, Cao X, et al. Hsa_circ_0014717 is downregulated in colorectal cancer and inhibits tumor growth by promoting p16 expression. Biomed Pharmacother. 2018 Feb;98:775–782.
   PubMed Web of Science ®Google Scholar
• Wang M, Chen B, Ru Z, et al. CircRNA circ-ITCH suppresses papillary thyroid cancer progression through miR-22-3p/CBL/β-catenin pathway. Biochem Biophys Res Commun. 2018 Sep 26;504(1):283–288.
   PubMedGoogle Scholar
• Yang Y, Ding L, Li Y, et al. Hsa_circ_0039411 promotes tumorigenesis and progression of papillary thyroid cancer by miR-1179/ABCA9 and miR-1205/MTA1 signaling pathways. J Cell Physiol. 2020 Feb;235(2):1321–1329.
   PubMed Web of Science ®Google Scholar
• Jiao X, Ye J, Wang X, et al. KIAA1199, a Target of MicoRNA-486-5p, promotes papillary thyroid cancer invasion by influencing Epithelial-Mesenchymal Transition (EMT). Med Sci Monit. 2019 Sep 10;25:6788–6796.
   PubMedGoogle Scholar
• Ding Q, He K, Luo T, et al. SSRP1 contributes to the malignancy of hepatocellular carcinoma and is negatively regulated by miR-497. Mol Ther. 2016 May;24(5):903–914.
   PubMedGoogle Scholar
• Çakmak HA, Demir M. MicroRNA and cardiovascular diseases. Balkan Med J. 2020 Feb 28;37(2):60–71.
   PubMed Web of Science ®Google Scholar
• Li M, Li W, Ren FQ, et al. miRNA-186 improves sepsis induced renal injury Via PTEN/PI3K/AKT/P53 Pathway. Open Med (Wars). 2020 Apr 4;15(1):254–260.
   PubMedGoogle Scholar
• Wu W, He K, Guo Q, et al. SSRP1 promotes colorectal cancer progression and is negatively regulated by miR-28-5p. J Cell Mol Med. 2019 May;23(5):3118–3129.
   PubMed Web of Science ®Google Scholar
• Yan H, Chen X, Li Y, et al. MiR-1205 functions as a tumor suppressor by disconnecting the synergy between KRAS and MDM4/E2F1 in non-small cell lung cancer. Am J Cancer Res. 2019 Feb 1;9(2):312–329.
   PubMed Web of Science ®Google Scholar
• Shi F, Deng Z, Zhou Z, et al. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling. J Cell Mol Med. 2019 Oct;23(10):6578–6594.
   PubMedGoogle Scholar
• Xue C, Cheng Y, Wu J, et al. Circular RNA CircPRMT5 accelerates proliferation and invasion of papillary thyroid cancer through regulation of miR-30c/E2F3 Axis. Cancer Manag Res. 2020 May 11;18:3285–3291.
   Google Scholar
• Ebbesen KK, Kjems J, Hansen TB. Circular RNAs: Identification, biogenesis and function. Biochim Biophys Acta. 2016 Jan;1859(1):254–260.
   Google Scholar
• Dong W, Bi J, Liu H, et al. Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis. Mol Cancer. 2019 May 17;18(1):95.
   PubMedGoogle Scholar
• Hu W, Han Q, Zhao L, et al. Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR-185/TGF-β1. J Cell Physiol. 2019 Feb;234(2):1469–1476.
   PubMed Web of Science ®Google Scholar
• Wang H, Yan X, Zhang H, et al. CircRNA circ_0067934 overexpression correlates with poor prognosis and promotes thyroid carcinoma progression. Med Sci Monit. 2019 Feb 19;25:1342–1349.
   PubMed Web of Science ®Google Scholar
• Yao Y, Chen X, Yang H, et al. Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis. J Exp Clin Cancer Res. 2019 Jul 19;38(1):318.
   PubMedGoogle Scholar
• Sun T, Leung F, Lu WW. MiR-9-5p, miR-675-5p and miR-138-5p damages the strontium and LRP5-Mediated skeletal cell proliferation, differentiation, and adhesion. Int J Mol Sci. 2016 Feb 15;17(2):236.
   PubMedGoogle Scholar
• Guo J, Miao Y, Xiao B, et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 2009 Apr;24(4):652–657.
   PubMed Web of Science ®Google Scholar
• Xu Y, Han YF, Zhu SJ, et al. miRNA-148a inhibits cell growth of papillary thyroid cancer through STAT3 and PI3K/AKT signaling pathways. Oncol Rep. 2017 Nov;38(5):3085–3093.
   PubMed Web of Science ®Google Scholar
• Yi T, Zhou X, Sang K, et al. MicroRNA-1270 modulates papillary thyroid cancer cell development by regulating SCAI. Biomed Pharmacother. 2019 Jan;109:2357–2364.
   PubMed Web of Science ®Google Scholar
• Pan Y, Xu T, Liu Y, et al. Upregulated circular RNA circ_0025033 promotes papillary thyroid cancer cell proliferation and invasion via sponging miR-1231 and miR-1304. Biochem Biophys Res Commun. 2019 Mar 5;510(2):334–338.
   PubMed Web of Science ®Google Scholar
• Jin X, Wang Z, Pang W, et al. Upregulated hsa_circ_0004458 contributes to progression of papillary thyroid carcinoma by inhibition of miR-885-5p and activation of RAC1. Med Sci Monit. 2018 Aug 7;24:5488–5500.
   PubMed Web of Science ®Google Scholar
• Parisi T, Yuan TL, Faust AM, et al. Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues. Mol Cell Biol. 2007 Mar;27(6):2283–2293.
   PubMedGoogle Scholar
• Rodríguez JL, Boukaba A, Sandoval J, et al. Transcription of the MAT2A gene, coding for methionine adenosyltransferase, is up-regulated by E2F and Sp1 at a chromatin level during proliferation of liver cells. Int J Biochem Cell Biol. 2007;39(4):842–850.
   PubMedGoogle Scholar
• Hurst CD, Tomlinson DC, Williams SV, et al. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification. Oncogene. 2008 Apr 24;27(19):2716–2727.
   PubMedGoogle Scholar
• Vimala K, Sundarraj S, Sujitha MV, et al. Curtailing overexpression of E2F3 in breast cancer using siRNA (E2F3)-based gene silencing. Arch Med Res. 2012 Aug;43(6):415–422.
   PubMedGoogle Scholar
• Feng Z, Peng C, Li D, et al. E2F3 promotes cancer growth and is overexpressed through copy number variation in human melanoma. Onco Targets Ther. 2018 Aug 30;11:5303–5313.
   PubMed Web of Science ®Google Scholar
• Pei Y, Tang Z, Cai M, et al. The E2F3/miR-125a/DKK3 regulatory axis promotes the development and progression of gastric cancer. Cancer Cell Int. 2019 Aug 13;19(1):212.
   PubMed Web of Science ®Google Scholar
• Wang T, Du M, Zhang W, et al. MicroRNA-432 suppresses invasion and migration via E2F3 in nasopharyngeal carcinoma. Onco Targets Ther. 2019 Dec 19;19:11271–11280.
   Google Scholar
• Wang Y, Sun G, Wang C, et al. MiR-194-5p inhibits cell migration and invasion in bladder cancer by targeting E2F3. J BUON. 2018 Sep-Oct;23(5):1492–1499.
   PubMed Web of Science ®Google Scholar
• Sun FB, Lin Y, Li SJ, et al. MiR-210 knockdown promotes the development of pancreatic cancer via upregulating E2F3 expression. Eur Rev Med Pharmacol Sci. 2018 Dec;22(24):8640–8648.
   PubMed Web of Science ®Google Scholar